Reuters logo
BRIEF-Stemcells interim results show improvement in visual function and slowing of disease progression in phase I/II dry AMD trial
June 19, 2014 / 12:35 PM / 3 years ago

BRIEF-Stemcells interim results show improvement in visual function and slowing of disease progression in phase I/II dry AMD trial

June 19 (Reuters) - Stemcells <STEM.O:>

* Stemcells interim results show improvement in visual function and slowing of disease progression in phase i/ii dry amd trial

* Stemcells says interim results show 70 percent reduction in the rate of ga when comparedto the control eye

* Results show 65% reduction in rate of geographic atrophy in study eye compared to expected natural history of disease Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below